Sable Bio employs artificial intelligence to analyze large amounts of biomedical data in order to test possible drugs for toxicity.
sable bio has raised $3.8M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
sable bio's investors include Seedcamp, Episode 1, MMC Ventures, Siddhant Jayakumar.
sable bio is headquartered in London, United Kingdom.
Sable Bio employs artificial intelligence to analyze large amounts of biomedical data in order to test possible drugs for toxicity.
sable bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"sable bio — Funding & Investors." VCBacked, February 11, 2026, https://www.vcbacked.co/company/sable-bio. Accessed October 19, 2026.
VCBacked. (2026). sable bio — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/sable-bio
{{cite web |title=sable bio — Funding & Investors |url=https://www.vcbacked.co/company/sable-bio |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated